"Recombinant Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins prepared by recombinant DNA technology.
Descriptor ID |
D011994
|
MeSH Number(s) |
D12.776.828
|
Concept/Terms |
Recombinant Proteins- Recombinant Proteins
- Proteins, Recombinant
- Proteins, Biosynthetic
- Biosynthetic Proteins
Proteins, Recombinant DNA- Proteins, Recombinant DNA
- DNA Proteins, Recombinant
- Recombinant DNA Proteins
- DNA Recombinant Proteins
- Proteins, DNA Recombinant
- Recombinant Proteins, DNA
|
Below are MeSH descriptors whose meaning is more general than "Recombinant Proteins".
Below are MeSH descriptors whose meaning is more specific than "Recombinant Proteins".
This graph shows the total number of publications written about "Recombinant Proteins" by people in this website by year, and whether "Recombinant Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 60 | 61 |
1995 | 2 | 92 | 94 |
1996 | 3 | 87 | 90 |
1997 | 1 | 79 | 80 |
1998 | 2 | 81 | 83 |
1999 | 0 | 89 | 89 |
2000 | 1 | 85 | 86 |
2001 | 2 | 62 | 64 |
2002 | 4 | 82 | 86 |
2003 | 6 | 87 | 93 |
2004 | 7 | 108 | 115 |
2005 | 4 | 73 | 77 |
2006 | 2 | 81 | 83 |
2007 | 3 | 69 | 72 |
2008 | 3 | 63 | 66 |
2009 | 4 | 58 | 62 |
2010 | 6 | 47 | 53 |
2011 | 3 | 49 | 52 |
2012 | 5 | 40 | 45 |
2013 | 2 | 57 | 59 |
2014 | 1 | 38 | 39 |
2015 | 1 | 38 | 39 |
2016 | 6 | 33 | 39 |
2017 | 2 | 42 | 44 |
2018 | 4 | 24 | 28 |
2019 | 2 | 25 | 27 |
2020 | 2 | 27 | 29 |
2021 | 3 | 16 | 19 |
2022 | 0 | 5 | 5 |
2023 | 1 | 4 | 5 |
2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Recombinant Proteins" by people in Profiles.
-
Bivalirudin: The misunderstood alternative to heparin. Paediatr Anaesth. 2024 05; 34(5):394-395.
-
Retrospective Comparison of Recombinant Activated Factor VII Versus 4-Factor Prothrombin Complex Concentrate in Cardiac Surgical Patients. J Cardiothorac Vasc Anesth. 2024 Feb; 38(2):388-393.
-
Safety and efficacy of zinpentraxin alfa as monotherapy or in combination with ruxolitinib in myelofibrosis: stage I of a phase II trial. Haematologica. 2023 10 01; 108(10):2730-2742.
-
Hematopoietic Stimulation During Impella 5.5 Support to Avoid Transfusions in a Jehovah's Witness. ASAIO J. 2023 08 01; 69(8):e384-e387.
-
Vaccine-linked chemotherapy improves cardiac structure and function in a mouse model of chronic Chagas disease. Front Cell Infect Microbiol. 2023; 13:1106315.
-
Second-Generation CD73 Inhibitors Based on a 4,6-Biaryl-2-thiopyridine Scaffold. ChemMedChem. 2023 04 03; 18(7):e202200594.
-
From concept to delivery: a yeast-expressed recombinant protein-based COVID-19 vaccine technology suitable for global access. Expert Rev Vaccines. 2023 Jan-Dec; 22(1):495-500.
-
Cost-effectiveness of bivalirudin in pediatric ventricular assist devices. J Heart Lung Transplant. 2023 03; 42(3):390-397.
-
A novel multi-epitope recombinant protein elicits an antigen-specific CD8+?T cells response in Trypanosoma cruzi-infected mice. Vaccine. 2022 10 26; 40(45):6445-6449.
-
Vaccine-linked chemotherapy with a low dose of benznidazole plus a bivalent recombinant protein vaccine prevents the development of cardiac fibrosis caused by Trypanosoma cruzi in chronically-infected BALB/c mice. PLoS Negl Trop Dis. 2022 09; 16(9):e0010258.